OraSure Technologies, Inc.

NasdaqGS:OSUR Stock Report

Market Cap: US$272.3m

OraSure Technologies Past Earnings Performance

Past criteria checks 1/6

OraSure Technologies has been growing earnings at an average annual rate of 21.8%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 19.1% per year. OraSure Technologies's return on equity is 2.7%, and it has net margins of 5.1%.

Key information

21.8%

Earnings growth rate

19.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate19.1%
Return on equity2.7%
Net Margin5.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Nov 14
Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Recent updates

OraSure Technologies: Discounted Assets With An Attractive Free Call Option

Dec 11

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Nov 14
Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

Nov 08
Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

OraSure: An NCAV Diamond In The COVID Rough

Nov 04

OraSure Technologies: Nursing A COVID-19 Hangover

Sep 10

OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

May 11
OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

Apr 17
Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01
Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Feb 29
Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Dec 20
OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Nov 08
Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Aug 09
Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

May 16
Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

May 13
Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Feb 17
Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

Jan 16
We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

OraSure wins $8.6M government contract for next-gen Ebola test

Sep 28

OraSure: Revenue Mix Continues To Present Risk

Sep 06

Biden administration ending free at-home COVID tests due to lack of funding

Aug 29

Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Invest In Growth?

Aug 11
Is OraSure Technologies (NASDAQ:OSUR) In A Good Position To Invest In Growth?

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Jun 14
Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Revenue & Expenses Breakdown

How OraSure Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqGS:OSUR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24224117826
30 Jun 24274277930
31 Mar 24305238431
31 Dec 23405549233
30 Sep 23453499934
30 Jun 234804410936
31 Mar 234753011338
31 Dec 22387-1711736
30 Sep 22328-4311837
30 Jun 22265-6411536
31 Mar 22243-4710734
31 Dec 21234-239534
30 Sep 21233-118936
30 Jun 2122758035
31 Mar 21199-47934
31 Dec 20172-157731
30 Sep 20158-147427
30 Jun 20146-27223
31 Mar 20156136721
31 Dec 19155176520
30 Sep 19150257318
30 Jun 19159207017
31 Mar 19161196917
31 Dec 18182206916
30 Sep 18177175716
30 Jun 18174155715
31 Mar 18174165814
31 Dec 17166315813
30 Sep 17145316010
30 Jun 17135315910
31 Mar 17126305710
31 Dec 16123205810
30 Sep 16125175811
30 Jun 16123126110
31 Mar 16122116210
31 Dec 1512086111
30 Sep 1511616312
30 Jun 1511416113
31 Mar 1511016212
31 Dec 14106-56512
30 Sep 1410746610
30 Jun 1410316510
31 Mar 14101-7679

Quality Earnings: OSUR has a large one-off loss of $17.2M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: OSUR's current net profit margins (5.1%) are lower than last year (10.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: OSUR's earnings have grown significantly by 21.8% per year over the past 5 years.

Accelerating Growth: OSUR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: OSUR had negative earnings growth (-77%) over the past year, making it difficult to compare to the Medical Equipment industry average (15%).

Return on Equity

High ROE: OSUR's Return on Equity (2.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 13:42
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OraSure Technologies, Inc. is covered by 17 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Charley JonesBarrington Research Associates, Inc.
Karen KoskiBTIG
Mark MassaroCanaccord Genuity